SRC and cancer: LL-2003 exhibited similar effects on cell viability, the phosphorylation of IGF-1R and Src, and induction of PARP cleavage in MCF7 human breast cancer cells, suggesting LL-2003 could be applicable to other types of cancers (Figure S5).